Florida Department of Health
4052 Bald Cypress Way, Tallahassee, FL, 32399-0700, United States
Overview
Florida Department of Health provides community health, people with disabilities, women's, children, & public health resource services.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- Communities
- Government
- Health Care
Investment portfolio
- Myosin Therapeutics
Led · Grant · Mar 2026
Myosin Therapeutics is developing MT-125, a novel dual inhibitor and its sole clinical candidate for glioblastoma. STAR-GBM is the company’s first human trial (Phase 1/2) and is designed to assess safety and identify the maximum tolerated dose, with early activity results expected within the coming year. The company previously raised a seed round of over $3 million earlier in 2025 and has received prior NIH support. The newly awarded $2.0 million grant from the Florida Department of Health is non-dilutive and earmarked for trial activities at the Mayo Clinic in Jacksonville. While the grant provides a short-term financial cushion and regional credibility, it does not cover the full costs of the planned trial or longer-term development, leaving the company dependent on additional fundraising. Management has been presenting at investor conferences to attract new capital, and the program’s binary near-term catalysts are positive Phase 1 data and subsequent funding to enable a Phase 2 expansion.
Team
No current team members are available.